Michal Silverberg
Managing Director at Novartis Venture Fund
Boston, Massachusetts
Writes $5M – $10M checks · typically $7.5M
Experience
- novartis venture fundManaging Directorcurrent2017 — present
- Takeda Ventures, Inc.Senior Partner2014 — 2017
- Novo NordiskSenior Director Business Development and New Product Commercialization2007 — 2013
- OSI PharmaceuticalsManager Business Development2006 — 2007
- MGVS (Multi Gene Vascular Systems)VP Business Development and Operation2003 — 2006
Education
- Columbia UniversityMA, Biotechnology2004 — 2005
- Tel Aviv UniversityMBA1998 — 2000
- University of HaifaBA, Economics & Business1995 — 1998
Skills & more
Clinical Development14Biotechnology15Pharmaceutical Industry23
From Michal's professional profile.
Deals · 1
ImmPACT Bio USA Inc.Board seat
via Novartis Venture Fund · filed Aug 2020 · $5.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Novartis Venture Fund
Aaron Nelson
Managing Director at Novartis Venture Fund
Adam Cotton
Principal at Novartis Venture Fund
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Anja Konig
Managing Director at Novartis Venture Fund
Anja König
Global Head at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Christoph Meier
Investor at Novartis Venture Fund





